The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC

PHASE1CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1989

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (23)

10003

Beth Israel Med Ctr / Peter Krueger Clinic, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Mem Sloan - Kettering Cancer Ctr, New York

10029

Mount Sinai Med Ctr, New York

10461

Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx

10465

Jack Weiler Hosp / Bronx Municipal Hosp, The Bronx

13210

SUNY / State Univ of New York, Syracuse

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

21287

Johns Hopkins Hosp, Baltimore

27710

Duke Univ Med Ctr, Durham

55455

Univ of Minnesota, Minneapolis

70112

Louisiana State Univ Med Ctr / Tulane Med School, New Orleans

Tulane Univ School of Medicine, New Orleans

90033

Los Angeles County - USC Med Ctr, Los Angeles

92037

LaJolla Veterans Administration Med Ctr, La Jolla

94115

Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco

94305

Stanford Univ School of Medicine, Stanford

921036325

Univ of California / San Diego Treatment Ctr, San Diego

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

02215

Beth Israel Deaconess - West Campus, Boston

Beth Israel Deaconess Med Ctr, Boston

Unknown

Univ of Pittsburgh Med School, Pittsburgh

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000999 - The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC | Biotech Hunter | Biotech Hunter